Aeterna Zentaris is a specialty biopharmaceutical company focused on developing and commercializing, principally through out-licensing, macimorelin, an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency (AGHD), a rare endocrine disorder. Aeterna Zentaris owns the worldwide rights to macimorelin and has significant patent protection left. The Companyâs U.S. composition of matter patent expires in 2022 and our U.S. utility patent runs through 2027. Macimorelin was invented and first synthesized by the research group of Professor Martinez at the University of Montpellier, Centre National de la Recherche Scientitifique (CNRS). This transpired from a long-lasting research collaboration with Aeterna Zentaris. Aeterna Zentaris later in-licensed macimorelin as a development candidate from the CNRS and proceeded with the pre-clinical and clinical development of the compound. On January 17, 2018, Aeterna Zentaris announced that it had, through a wholly-owned subsidiary, entered into a license and assignment agreement with a wholly-owned subsidiary of Strongbridge Ireland Ltd. to carry out development, manufacturing, registration and commercialization of Macrilen⢠(macimorelin) in the United States and Canada. For more information about Macrilen⢠(macimorelin) in the U.S. and Canada visit: www.Strongbridgebio.com. Our licensing agreement of Macrilen⢠for the U.S. and Canada with Strongbridge demonstrates the value of our development initiatives and better positions us to maximize significant value of Macrilen⢠by licensing in territories outside the United States and Canada. Source
No articles found.
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...
Headquartered in Mountain View, California, IGM...
MediWound is a fully integrated biopharmaceutical company focused on developing, m...
MediWound is a fully integrated biopharmaceutic...
Geron is a late-stage clinical biopharmaceutical company focused on the developmen...
Geron is a late-stage clinical biopharmaceutica...
Eidos is a clinical stage biopharmaceutical company focused on addressing the larg...
Eidos is a clinical stage biopharmaceutical com...
Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet...
Theratechnologies (TSX: TH) is a specialty phar...
Dova is a pharmaceutical company focused on acquiring, developing and commercializ...
Dova is a pharmaceutical company focused on acq...
Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focu...
Strongbridge Biopharma is a global commercial-s...
Join the National Investor Network and get the latest information with your interests in mind.